TrialNeuro-oncology2017

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.

Mark W Kieran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.